Vyne Therapeutics Inc. · NASDAQ:VYNE
Domzalski David had 12,214 Vyne Therapeutics Inc. shares withheld for tax (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Domzalski David (Director, PRESIDENT AND CEO) had 12,214 Vyne Therapeutics Inc. shares withheld for tax at US$0.65 for US$7,939, leaving 426,565 shares. Filed Jul 2, 2026 (Form 4).
- Withheld for tax
- 12,214 shares
- Price
- US$0.65
- Value
- US$7,939
- Holding after
- 426,565 shares
- Trading plan
- No
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Shares withheld for tax | 12,214 | US$0.65 | 426,565 | Direct |
Source
Related
- Vyne Therapeutics Inc.
- Domzalski David
- Vyne Therapeutics Inc. shareholders
- Form 4 · Domzalski David · Jul 24, 2026
- Form 4 · Domzalski David · Jun 2, 2026
- Form 4 · Domzalski David · Apr 2, 2026
- Form 4 · Zeronda Tyler · Jul 24, 2026
- Form 4 · Stuart Iain · Jul 24, 2026
- Form 4 · Harsch Mutya · Jul 24, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 17, 2026
- Schedule 13G/A · Zhang Xiaofan · Jul 14, 2026